3rd Quarter - Report
NVG, LLC for GLOBAL BLOOD THERAPEUTICS
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Legislation to create care sickle cell treatment centers. H.R.8855/S.4866 - Sickle Cell Disease Treatment Centers Act of 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| IRENE BUENO | — |
| LISA GERMAN FOSTER | — |
| EDEN SHIFERAW | — |
Budget/Appropriations BUD
Funding and report language for sickle cell disease programs within the FY 23 LHHS.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.